SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?

To: jimmy c who wrote (217)12/28/1998 10:31:00 PM
From: Research Week  Read Replies (1) | Respond to of 804
 
New Research Recommendation

As of the close of the markets on December 24, 1998, we have initiated coverage of Celgene Corp. with a Strong Buy recommendation.

Research Week Inc.



To: jimmy c who wrote (217)12/28/1998 11:12:00 PM
From: Miljenko Zuanic  Respond to of 804
 
Jimmy:

CELG was strong buy at ~8. At ~15 it is buy on weakness, unless there is new partner announcement (IMIDs, SelCIDs, Ritalin,..), and/or convertible finance at premium to +15.

IMO!

Miljenko



To: jimmy c who wrote (217)12/29/1998 8:11:00 AM
From: Len  Read Replies (1) | Respond to of 804
 
Jimmy,
After yesterday, I am thinking of dumping it. You think it has room to run??

Len


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News